Search research articles
Contact Us
Filters
Showing results (341-350 of 429) with videos related to
Page
of 43
Sort By:
Cancer Chemotherapy and Pharmacology
|
September 21, 2005
Biomarkers for assessment of pharmacologic activity for a vascular endothelial growth factor (VEGF) receptor inhibitor, PTK787/ZK 222584 (PTK/ZK): translation of biological activity in a mouse melanoma metastasis model to phase I studies in patients with advanced colorectal cancer with liver metastases
Lucy Lee, Sunil Sharma, Bruno Morgan, et al.
The Journal of Arthroplasty
|
November 7, 2025
2025 ICM: Mycobacterium
Atthakorn Jarusriwanna, Yoshi Pratama Djaja, Muhammad Amin Chinoy, et al.
Investigational New Drugs
|
November 18, 2016
A phase 1 study combining the HER3 antibody seribantumab (MM-121) and cetuximab with and without irinotecan
James M Cleary, Autumn J McRee, Geoffrey I Shapiro, et al.
Molecular Cancer Therapeutics
|
October 11, 2018
Histone Deacetylase Inhibition Has Targeted Clinical Benefit in <i>ARID1A</i>-Mutated Advanced Urothelial Carcinoma
Sumati Gupta, Daniel J Albertson, Timothy J Parnell, et al.
Cancer Chemotherapy and Pharmacology
|
July 10, 2016
Phase 1 study to evaluate the effect of the MEK inhibitor trametinib on cardiac repolarization in patients with solid tumours
Amita Patnaik, Anthony Tolcher, Kyriakos P Papadopoulos, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine
|
October 10, 2024
Insights, recommendations, and research priorities for central sleep apnea: report from an expert panel
Vaishnavi Kundel, Anjali Ahn, Michael Arzt, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine
|
August 21, 2025
Evaluation and management of obstructive sleep apnea in adults hospitalized for medical care: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment
Dennis H Auckley, Reena Mehra, Karin G Johnson, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine
|
August 21, 2025
Evaluation and management of obstructive sleep apnea in adults hospitalized for medical care: an American Academy of Sleep Medicine clinical practice guideline
Reena Mehra, Dennis H Auckley, Karin G Johnson, et al.
Seminars in Oncology
|
October 3, 2003
Pharmacology of oxaliplatin in solid tumor patients with hepatic dysfunction: a preliminary report of the National Cancer Institute Organ Dysfunction Working Group
James H Doroshow, Timothy W Synold, David Gandara, et al.
American Journal of Clinical Oncology
|
August 3, 2005
A Phase II study of intravenous exatecan administered daily for 5 days, every 3 weeks to patients with biliary tract cancers
Ghassan K Abou-Alfa, Eric K Rowinsky, Yehuda Z Patt, et al.
Page
of 43
Search research articles
Search
Showing results (341-350 of 429) with videos related to
Sort By:
Page
of 43
Cancer Chemotherapy and Pharmacology
|
September 21, 2005
Biomarkers for assessment of pharmacologic activity for a vascular endothelial growth factor (VEGF) receptor inhibitor, PTK787/ZK 222584 (PTK/ZK): translation of biological activity in a mouse melanoma metastasis model to phase I studies in patients with advanced colorectal cancer with liver metastases
Lucy Lee, Sunil Sharma, Bruno Morgan, et al.
The Journal of Arthroplasty
|
November 7, 2025
2025 ICM: Mycobacterium
Atthakorn Jarusriwanna, Yoshi Pratama Djaja, Muhammad Amin Chinoy, et al.
Investigational New Drugs
|
November 18, 2016
A phase 1 study combining the HER3 antibody seribantumab (MM-121) and cetuximab with and without irinotecan
James M Cleary, Autumn J McRee, Geoffrey I Shapiro, et al.
Molecular Cancer Therapeutics
|
October 11, 2018
Histone Deacetylase Inhibition Has Targeted Clinical Benefit in <i>ARID1A</i>-Mutated Advanced Urothelial Carcinoma
Sumati Gupta, Daniel J Albertson, Timothy J Parnell, et al.
Cancer Chemotherapy and Pharmacology
|
July 10, 2016
Phase 1 study to evaluate the effect of the MEK inhibitor trametinib on cardiac repolarization in patients with solid tumours
Amita Patnaik, Anthony Tolcher, Kyriakos P Papadopoulos, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine
|
October 10, 2024
Insights, recommendations, and research priorities for central sleep apnea: report from an expert panel
Vaishnavi Kundel, Anjali Ahn, Michael Arzt, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine
|
August 21, 2025
Evaluation and management of obstructive sleep apnea in adults hospitalized for medical care: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment
Dennis H Auckley, Reena Mehra, Karin G Johnson, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine
|
August 21, 2025
Evaluation and management of obstructive sleep apnea in adults hospitalized for medical care: an American Academy of Sleep Medicine clinical practice guideline
Reena Mehra, Dennis H Auckley, Karin G Johnson, et al.
Seminars in Oncology
|
October 3, 2003
Pharmacology of oxaliplatin in solid tumor patients with hepatic dysfunction: a preliminary report of the National Cancer Institute Organ Dysfunction Working Group
James H Doroshow, Timothy W Synold, David Gandara, et al.
American Journal of Clinical Oncology
|
August 3, 2005
A Phase II study of intravenous exatecan administered daily for 5 days, every 3 weeks to patients with biliary tract cancers
Ghassan K Abou-Alfa, Eric K Rowinsky, Yehuda Z Patt, et al.
Page
of 43